Skip to main content

Table 1 Patient characteristics and proportion included in a cancer patient pathway for colorectal, lung, breast and prostate cancer patients diagnosed in 2015–2016 in Norway

From: Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

  Colorectal Lung Breast Prostate
N % CPP N % CPP N % CPP N % CPP
Year of diagnosis
 2015 4133 77.7% 2901 76.6% 3409 90.0% 4971 61.5%
 2016 4118 85.1% 2886 84.9% 3334 96.5% 4995 74.1%
Age group
 18–49 487 68.8% 135 84.4% 1282 94.5% 133 77.4%
 50–59 906 83.8% 566 85.2% 1623 92.9% 1266 73.7%
 60–69 2106 84.9% 1830 84.9% 2019 93.5% 4035 75.8%
 70–79 2643 83.8% 2160 82.8% 1074 92.8% 3292 67.1%
 80–89 1799 79.6% 999 68.6% 586 92.0% 1102 38.6%
 90+ 310 61.0% 97 51.5% 159 89.9% 138 16.7%
Sex
 Female 4034 80.3% 2769 80.0% 6743 93.2%   
 Male 4217 82.4% 3018 81.5%    9966 67.8%
Stagea
 A 1779 78.7% 1056 90.7% 5394 94.4% 4793 63.7%
 B 4128 86.4% 1621 87.9% 764 94.4% 2705 77.3%
 C 1720 75.4% 2332 75.0% 233 76.4% 620 58.7%
 D 624 72.4% 778 69.5% 352 83.5% 1848 67.3%
Marital status
 Single 3669 78.5% 2797 79.2% 3146 93.3% 2970 65.9%
 Married 4582 83.7% 2990 82.2% 3597 93.2% 6996 68.6%
Education
 Low 2515 79.5% 2386 79.0% 1523 92.1% 2126 63.8%
 Intermediate 3943 82.3% 2716 81.5% 3039 93.3% 5057 69.1%
 High 1793 82.0% 685 84.1% 2181 93.9% 2783 68.4%
Income
 Low 1109 79.4% 912 75.8% 723 91.0% 800 59.8%
 Intermediate 5180 81.2% 3951 80.7% 3318 92.6% 5800 66.5%
 High 1962 83.2% 924 86.0% 2702 94.6% 3366 71.9%
Region
 South-East 4429 80.1% 3196 79.8% 3929 94.7% 5695 69.0%
 West 1759 82.6% 1236 81.1% 1314 93.1% 1976 60.0%
 Mid 1223 80.0% 747 77.9% 923 84.9% 1466 73.5%
 North 840 87.7% 608 88.5% 577 96.9% 829 67.4%
Comorbidity
 No admissions 310 82.3% 90 90.0% 1482 94.7% 1188 59.1%
 0 5949 82.4% 3144 82.7% 4599 93.0% 6960 71.7%
 1–2 1675 79.5% 2132 79.5% 576 92.4% 1563 60.6%
 3+ 317 71.9% 421 71.0% 86 87.2% 255 43.9%
  1. Abbreviation: CPP cancer patient pathways
  2. aColorectal, lung and prostate: Localised (A), Regional (B), Metastasis (C), Unknown (D). Breast: Stage I-II (A), Stage III (B), Stage IV (C), Unknown (D)